Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Alopecia: early-phase trial registry
7 of 14 indexed Alopecia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,230 of 28,707 conditions by registered trial count.
14 US clinical trials · 7 currently recruiting · #1,230 of 28,707 conditions by registered trial count
Alopecia: 14 US clinical trials tracked, 7 recruiting.
Alopecia is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Hordinsky, Maria K., MD, running 1 of these trials.
Enrollment posture brief
Registry condition alopecia
OPEN 7 | RECR 50% | LATE 1 | EARLY 4 | RANK #1230 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Alopecia lists 7 open slots (50% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Alopecia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Alopecia is recruiting above its size-band peers.
7 of 14 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Alopecia trials is spread across many organizations.
Hordinsky, Maria K., MD accounts for 1 of 14 trials (7.1%). 14 distinct sponsors appear on at least one study for this condition label.
-
Most Alopecia trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 14 trials that report a genuine target (sentinel values excluded). 10 of those (71.4%) plan for fewer than 100 participants.
-
Alopecia research is mostly interventional.
13 interventional and 1 observational studies make up this index (92.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
14 total, page 1 of 1
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
NCT05723198
Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands Region
Charles Mays
NCT07422376
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
Cooler Heads Care
NCT05484973
Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
Acorn Biolabs
NCT07107841
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
University of California, San Francisco
NCT06215469
Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors
St. Jude Children's Research Hospital
NCT04764357
Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color
Montefiore Medical Center
NCT05213936
Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning
Recens Medical
NCT06999408
A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors
Memorial Sloan Kettering Cancer Center
NCT05778825
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Applied Biology
NCT02206802
A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)
Allergan
NCT01904721
Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice
Hordinsky, Maria K., MD
NCT00177099
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
Icahn School of Medicine at Mount Sinai
NCT03689452
Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia
University of Arizona
NCT04554732
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Alopecia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Alopecia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Alopecia page
14 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Alopecia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Hordinsky, Maria K., MD sponsors the most Alopecia trials on record, review their full trial history before evaluating a specific study. See Hordinsky, Maria K., MD's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Alopecia condition card totals 14 registered trials; most-linked intervention Paxman Scalp Cooling System; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.